Volume 8, Issue 2 (Annals of Bariatric Surgery 2019)                   ABS 2019, 8(2): 26-29 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Hatami M, Pazouki A, Kabir A. 25-Hydroxy Vitamin D3 in Patients with Morbid Obesity of Wait-listed Bariatric Surgery: It’s Association with Adiposity and Metabolic Indices. ABS 2019; 8 (2) :26-29
URL: http://annbsurg.iums.ac.ir/article-1-251-en.html
Abstract:   (791 Views)
Background: Vitamin D3 deficiency is associated with insulin resistance and metabolic syndrome. Although, the evidence was not conclusive. The aim of this study is to investigate the relationship between serum 25-hydroxy vitamin D3 (25(OH) D3) levels with some adiposity and metabolic indices related to metabolic syndrome.
Material and Methods: In this cross-sectional study, the anthropometric, body composition information, the clinical laboratory tests including fasting blood sugar (FBS), insulin, lipid profile, liver enzymes, and serum 25(OH) D3 of 3750 patients with morbid obesity are extracted from Iran National Obesity Surgery Database. HOMA-IR and QUICKI were computed based on the standard formula. Associations were tested using analysis of variance and Kruskal–Wallis tests.
Results: Approximately 69% of patients with morbid obesity had sub-optimal vitamin D3 levels (<20 ng/mL). An inverse significant relationship between serum 25(OH) D3 and body weight, body fat percentage, waist, and hip circumstance was observed (P-Value <0.05 for all). Low serum 25(OH) D3 levels are significantly associated with higher FBS and A1C, dyslipidemia (higher LDL and TG), and also the elevated level of liver function enzymes (P-Value <0.05 for all). Moreover, the patient with the higher serum 25(OH) D3 had a lower level of HOMA-IR and higher insulin sensitivity (QUICKI index); although this association was not statistically significant.
Conclusion: Vitamin D3 deficiency has been associated with adiposity, impaired glucose metabolism, and metabolic disorders related to insulin resistance. Thus, vitamin D3 supplementation could be a potential approach in treatment or decrease the metabolic complication of obesity before and after bariatric surgery.
Full-Text [PDF 440 kb]   (565 Downloads)    
Type of Study: Original | Subject: Endocrinology
Received: 2020/12/26 | Accepted: 2020/12/31 | ePublished: 2019/12/26

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Annals of Bariatric Surgery

Designed & Developed by : Yektaweb